US › Healthcare

Connect Biopharma Holdings Ltd (CNTB)

US · Healthcare · Biotechnology

$1.29+4.03%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$2.9M

Revenue YoY

+6018.8%

Net profit

$-36.7M

EPS

$-0.27

EPS estimate

$-0.32

Net margin

-1,249.0%

EPS came in at -0.27 against a street estimate of -0.32 — a beat of 15.6%.

Key statistics

Market cap

$128.5M

Forward P/E

0.8

P/B

4.78

Book value

$0.43

EPS (TTM)

$-1.19

52-week high

$3.82

52-week low

$1.23

50-day MA

$2.25

200-day MA

$2.46

Beta

-0.18

Analyst view

Analysts rate Connect Biopharma Holdings Ltd a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $7.25.

Shareholding

Insiders

29.68%

Institutions

56.13%

Largest institutional holders

Fund	Stake
Quadrature Capital Limited	0.07%
EverSource Wealth Advisors, LLC	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Connect Biopharma Holdings Ltd — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.